New Norway: Planning to transfer 30% of Guo Xin Huijin's shares to Stone Pharmaceutical Holdings for 230 million yuan.

The Xinuo announcement stated that the company intends to sell its 30.0704% stake in Guo Xin Huijin to Stone Pharmaceutical Holdings for 230 million yuan. After the transfer is completed, the company will no longer hold any shares in Guo Xin Huijin. The transaction has been approved by the company's board of directors and still requires approval from the shareholders' meeting. The transaction price was based on the evaluation results of Guo Rongxinghua Asset Appraisal Co., Ltd., with an appreciation rate of 94.85%. The proceeds will be used to supplement the company's daily operational funds. Guo Xin Huijin is a full-media communication business platform with mobile information clients and a full-media matrix at its core.